SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | n/a |
| Book Value / Share | n/a |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | n/a |
| Net Income | n/a |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | n/a |
| Cash from Investing | n/a |
| Cash from Financing | n/a |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Morgan Stanley | 0.00 | -100.00 | |
| 13G/A | Tang Capital Partners Lp | 3.00 | -63.54 | |
| 13G/A | Panacea Innovation Ltd | 0.00 | -100.00 | |
| 13G/A | Sofinnova Investments, Inc. | 0.00 | -100.00 | |
| 13G/A | Franklin Resources Inc | 0.00 | ||
| 13G | Suvretta Capital Management, Llc | 5.50 | -44.68 | |
| 13G/A | Vanguard Group Inc | 4.70 | -7.36 | |
| 13G | Beryl Capital Management LLC | 9.90 | ||
| 13G/A | Avoro Capital Advisors LLC | 0.00 | -100.00 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Eventide Asset Management, Llc | 0.00 | -100.00 | |
| 13G/A | Prudential Financial Inc | 0.70 | -88.36 | |
| 13G/A | Jennison Associates Llc | 0.00 | -100.00 | |
| 13G/A | BlackRock, Inc. | 3.40 | -59.34 | |
| 13G | Citadel Advisors Llc | 0.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| ACET – Adicet Bio, Inc. | ACIU – AC Immune SA |
| ACRV – Acrivon Therapeutics, Inc. | ADMA – ADMA Biologics, Inc. |
| AFMD – Affimed N.V. |